自动乳腺超声联合超声造影定量参数早期预测乳腺癌新辅助化疗反应
结果显示ΔV、ΔTTP和ΔPI是pCR的独立预测因子,CEUS-ABUS联合模型AUC最高(0.950),优于单独CEUS(0.918)或ABUS(0.891)。
要点
- ΔV、ΔTTP、ΔPI是预测pCR的独立因子。
- CEUS-ABUS联合模型预测效能最高,AUC达0.950。
- 联合模型可用于临床优化乳腺癌新辅助化疗决策。
关键影像表现/征象
- CEUS测量参数包括上升时间(RT)、达峰时间(TTP)、峰值强度(PI)、流入斜率(WIS)和流入曲线下面积(Wi-AUC)。
- ABUS测量冠状面和矢状面最大肿瘤直径并计算肿瘤体积(V)。
- 比较两个治疗时间点各参数的差值(Δ)。
诊断标准与关键数值
- ΔV、ΔTTP和ΔPI为pCR的独立预测因子。
- CEUS-ABUS联合模型AUC为0.950,CEUS模型AUC为0.918,ABUS模型AUC为0.891。
局限性
- 未报告外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This prospective study was aimed at evaluating the role of automated breast ultrasound (ABUS) and contrast-enhanced ultrasound (CEUS) in the early prediction of treatment response to neoadjuvant chemotherapy (NAC) in patients with breast cancer.
METHODS: Forty-three patients with pathologically confirmed invasive breast cancer treated with NAC were included. The standard for evaluation of response to NAC was based on surgery within 21 d of completing treatment. The patients were classified as having a pathological complete response (pCR) and a non-pCR. All patients underwent CEUS and ABUS 1 wk before receiving NAC and after two treatment cycles. The rising time (RT), time to peak (TTP), peak intensity (PI), wash-in slope (WIS) and wash-in area under the curve (Wi-AUC) were measured on the CEUS images before and after NAC. The maximum tumor diameters in the coronal and sagittal planes were measured on ABUS, and the tumor volume (V) was calculated. The difference (∆) in each parameter between the two treatment time points was compared. Binary logistic regression analysis was used to identify the predictive value of each parameter.
RESULTS: ∆V, ∆TTP and ∆PI were independent predictors of pCR. The CEUS-ABUS model achieved the highest AUC (0.950), followed by those based on CEUS (0.918) and ABUS (0.891) alone.
CONCLUSION: The CEUS-ABUS model could be used clinically to optimize the treatment of patients with breast cancer.
引用
- Xie, Chen, Wang, et al. Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer. Ultrasound Med Biol. 2023. PMID: 37100671. doi:10.1016/j.ultrasmedbio.2023.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。